Effects of ABO matching of platelet transfusions in critically ill children Journal Article


Authors: Nellis, M. E.; Goel, R.; Karam, O.; Cushing, M. M.; Davis, P. J.; Steiner, M. E.; Tucci, M.; Stanworth, S. J.; Spinella, P. C.; on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network; on behalf of the Pediatric Critical Care Blood Research Network (BloodNet); on behalf of the P(3)T Investigators
Contributors: Killinger, J. S.; Sturhahn, M.
Article Title: Effects of ABO matching of platelet transfusions in critically ill children
Abstract: Objectives: To determine if transfusing ABO compatible platelets has a greater effect on incremental change in platelet count as compared to ABO incompatible platelets in critically ill children. Design: Secondary analysis of a prospective, observational study. Transfusions were classified as either ABO compatible, major incompatibility, or minor incompatibility. The primary outcome was the incremental change in platelet count. Transfusion reactions were analyzed as a secondary outcome. Setting: Eighty-two PICUs in 16 countries. Patients: Children (3 d to 16 yr old) were enrolled if they received a platelet transfusion during one of the predefined screening weeks. Interventions: None. Measurements and Main Results: Five-hundred three children were enrolled and had complete ABO information for both donor and recipient, as well as laboratory data. Three-hundred forty-two (68%) received ABO-identical platelets, 133 (26%) received platelets with major incompatibility, and 28 (6%) received platelets with minor incompatibility. Age, weight, proportion with mechanical ventilation or underlying oncologic diagnosis did not differ between the groups. After adjustment for transfusion dose, there was no difference in the incremental change in platelet count between the groups; the median (interquartile range) change for ABO-identical transfusions was 28 x 10(9) cells/L (8-68 x 10(9) cells/L), for transfusions with major incompatibility 26 x 10(9) cells/L (7-74 x 10(9) cells/L), and for transfusions with minor incompatibility 54 x 10(9) cells/L (14-81 x 10(9) cells/L) (p = 0.37). No differences in count increment between the groups were noted for bleeding (p = 0.92) and nonbleeding patients (p = 0.29). There were also no differences observed between the groups for any transfusion reaction (p = 0.07). Conclusions: No differences were seen in the incremental change in platelet count nor in transfusion reactions when comparing major ABO incompatible platelet transfusions with ABO compatible transfusions in a large study of critically ill children. Studies in larger, prospectively enrolled cohorts should be performed to validate whether ABO matching for platelet transfusions in critically ill children is necessary.
Keywords: pediatrics; critical illness; impact; platelet transfusion; abo compatibility; nonidentical platelets; increments
Journal Title: Pediatric Critical Care Medicine
Volume: 20
Issue: 2
ISSN: 1529-7535
Publisher: Lippincott Williams & Wilkins  
Date Published: 2019-03-01
Start Page: E61
End Page: E69
Language: English
ACCESSION: WOS:000457805300002
DOI: 10.1097/pcc.0000000000001779
PROVIDER: wos
PUBMED: 30422914
PMCID: PMC6709973
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors